NewGenIvf Group Limited (NASDAQ:NIVF) Stock Short Interest Report for October

NewGenIvf Group Limited (NASDAQ:NIVF – Get Free Report) was the target of a large growth in short interest in October. As of October 15th, there was short interest totaling 2,470,389 shares, a growth of 3,427.1% from the September 30th total of 70,041 shares. Based on an average daily trading volume, of 33,175,029 shares, the days-to-cover ratio is presently 0.1 days. Currently, 325.1% of the company’s stock are sold short.

NewGenIvf Group Stock Down 0.4%

Shares of NIVF stock traded down $0.01 during trading hours on Tuesday, hitting $1.16. The company’s stock had a trading volume of 159,341 shares, compared to its average volume of 409,889. The company has a 50 day moving average of $23.82 and a 200 day moving average of $463.22. NewGenIvf Group has a 12-month low of $1.13 and a 12-month high of $20,960.64.

NewGenIvf Group (NASDAQ:NIVF – Get Free Report) last released its quarterly earnings data on Wednesday, October 7th. The company reported ($111.55) earnings per share for the quarter, missing analysts’ consensus estimates of $581.76 by ($693.31). The firm had revenue of $0.96 million for the quarter, compared to analysts’ expectations of $20.10 million. As a group, equities research analysts forecast that NewGenIvf Group will post 1365.44 earnings per share for the current year.

Analyst Ratings Changes

NIVF has been the topic of several research reports. Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a research note on Friday, July 24th. Wall Street Zen cut shares of NewGenIvf Group to a “strong sell” rating in a research report on Saturday. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat, the company currently has an average rating of “Sell”.

Read Our Latest Analysis on NIVF

NewGenIvf Group Company Profile

(Get Free Report)

NewGenIvf Group Limited is a reproductive-healthcare company focused on fertility treatment and assisted reproductive technology. Through its operating businesses, the company provides services intended to help individuals and couples pursue pregnancy, including in vitro fertilization (IVF) and related fertility-care procedures.

Its services may include fertility consultations, laboratory-based embryo procedures, intracytoplasmic sperm injection (ICSI), embryo transfer, fertility preservation, and genetic testing or screening associated with assisted reproduction.

See Also

Receive News & Ratings for NewGenIvf Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewGenIvf Group and related companies with MarketBeat.com's FREE daily email newsletter.